CytomX Therapeutics Inc. (CTMX) tumbled -5.1% or -0.86 to $15.99. It is approximately 496342 shares traded, which is 125.2% compare to the average total volume 396433. The market cap of CTMX is $719.66 million. The year to date change is 2.77%. The 52 week price range is from $12.51 to $35.0. Price of CTMX have changed 0.54% during last week. It have changed 12.56% over last month, 20.62% over last 3 months, -32.79% over last 6 months and -38.75% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CTMX is 15.00. It is -6.19% below current price. The 200-day Moving Averages for CTMX is 20.60. It is 28.83% above current price. The 52-week High is 35.0. It is 118.89% from the current price. The 52-week Low is 12.51. It is -21.76% from current price.
There are some statistics of CTMX. It is has market cap $719.66 million. The share outstanding is 45.01 million. The average volume is 396433. The percent of top 15 Institution holding is 133.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CTMX is -50.95%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CTMX is -11.90%.